Orphan Drug Trial Sponsors ‘Playing Catch-Up’ With Regulators – But Automation Can Help

 
• By Eliza Slawther
  
Automation can help trial sponsors to meet safety demands, an expert says (Shutterstock)

More from AI

More from Europe